GreenLight Biosciences Holdings, PBC

The momentum for this stock is not very good. GreenLight Biosciences Holdings, PBC is not very popular among insiders. Tradey thinks it is not wise to invest in GreenLight Biosciences Holdings, PBC.
Log in to see more information.

News

GreenLight Announces Completion of Merger with Fall Line Endurance Fund
GreenLight Announces Completion of Merger with Fall Line Endurance Fund

Globe Newswire LEXINGTON, Mass., July 24, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) (GreenLight or the Company) today announced the closing of its previously announced merger with SW MergerCo, Inc. (Merger Sub) and SW ParentCo, Inc. (Parent), pursuant to which Merger Sub merged ...\n more…

GreenLight Biosciences Announces Expiration of Tender Offer Period for Outstanding Shares
GreenLight Biosciences Announces Expiration of Tender Offer Period for Outstanding Shares

Globe Newswire Completion of Previously Announced Merger and Going Private Transaction Expected July 20, 2023\n GreenLight Biosciences\n\n GreenLight in field\n\nLEXINGTON, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) (GreenLight or the Company) today announced that it is...\n more…

GreenLight Biosciences Holdings (NASDAQ:GRNA) Short Interest Update
GreenLight Biosciences Holdings (NASDAQ:GRNA) Short Interest Update

Ticker Report GreenLight Biosciences Holdings (NASDAQ:GRNA Free Report) saw a large increase in short interest in June. As of June 15th, there was short interest totalling 4,310,000 shares, an increase of 27.9% from the May 31st total of 3,370,000 shares. Based on an average daily trading volume, of 707,...\n more…

GreenLight Biosciences (NASDAQ:GRNA) vs. Ambrx Biopharma (NYSE:AMAM) Head to Head Survey
GreenLight Biosciences (NASDAQ:GRNA) vs. Ambrx Biopharma (NYSE:AMAM) Head to Head Survey

Ticker Report Ambrx Biopharma (NYSE:AMAM Free Report) and GreenLight Biosciences (NASDAQ:GRNA Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, risk, ...\n more…

GreenLight Biosciences (NASDAQ:GRNA) versus Ambrx Biopharma (NYSE:AMAM) Financial Analysis
GreenLight Biosciences (NASDAQ:GRNA) versus Ambrx Biopharma (NYSE:AMAM) Financial Analysis

Zolmax GreenLight Biosciences (NASDAQ:GRNA Free Report) and Ambrx Biopharma (NYSE:AMAM Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst ...\n more…

Head-To-Head Review: GreenLight Biosciences (NASDAQ:GRNA) and Bio-Techne (NASDAQ:TECH)
Head-To-Head Review: GreenLight Biosciences (NASDAQ:GRNA) and Bio-Techne (NASDAQ:TECH)

Ticker Report GreenLight Biosciences (NASDAQ:GRNA Get Rating) and Bio-Techne (NASDAQ:TECH Get Rating) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, institutional ownership, profitability, valuation, ...\n more…